GMP Bio

Company

Related News

Oncotelic highlighted in editorial on biotech valuation and advancing drug pipelines

Apr 25, 2026

Oncotelic Therapeutics said it was featured in an editorial on how advancing drug pipelines are driving biotech valuation. The company cited its oncology pipeline, AI-enabled platform and 45% stake in GMP Bio.

Oncotelic Highlights OT-101 IP Expansion and Fair-Value Focus

Apr 20, 2026

Oncotelic Therapeutics announced expanded international intellectual property coverage for OT-101 across neurology, oncology and CNS drug-delivery technologies. The company also highlighted biotech valuation trends tied to clinical progress and its 45% stake in GMP Bio.